Amsterdam Molecular Therapeutics (AMT) IP B.V. – Trademark Portfolio
Entity Type: 99
Amsterdam Molecular Therapeutics (AMT) IP B.V. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 5 Nice Classification classes. The owner is based in Amsterdam.
Meibergdreef 61
Amsterdam 1105BA , NL
Showing of trademarks Trademarks
Trademark Classifications
Amsterdam Molecular Therapeutics (AMT) IP B.V.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Amsterdam Molecular Therapeutics (AMT) IP B.V. have?
Amsterdam Molecular Therapeutics (AMT) IP B.V. has 10 U.S. trademarks filed with the USPTO.
What trademark classes does Amsterdam Molecular Therapeutics (AMT) IP B.V. file in?
Amsterdam Molecular Therapeutics (AMT) IP B.V. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Amsterdam Molecular Therapeutics (AMT) IP B.V.'s trademark registration success rate?
Amsterdam Molecular Therapeutics (AMT) IP B.V. has a 0% trademark registration rate, with 0 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.